Sunday, 16 December 2018

68 drug formulations pricing set by NPPA

05 November 2018 | News

According to NPPA, while the retail price of 55 scheduled formulations has been fixed, that of 10 has been revised.

Drug price regulator National Pharmaceutical Pricing Authority (NPPA) has fixed prices as well as revised ceiling and retail prices of 68 formulations, including those used for treatment of diabetes, blood pressure and HIV.

According to NPPA, while the retail price of 55 scheduled formulations has been fixed, that of 10 has been revised.

Further, the authority has also fixed ceiling prices of three scheduled formulations.

NPPA has fixed or revised ceiling prices or retail prices of 68 formulations under Drugs (Prices Control) Order, 2013.

Comments

× Your session has been expired. Please click here to Sign-in or Sign-up
   New User? Create Account





Survey Box

Does Indian Pharma lack an innovation-friendly ecosystem?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls